Company / Operating Income per Share
Cardiff Oncology, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.74
FY2025
5-year range
-$1.02 / -$0.52
FY2021-FY2025
Trend
+27.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 3 years of decline, reaching $-0.74.
Based on SEC 10-K filings.
-0.74 in FY2025.
Improved from $-0.89 to $-0.74 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 27.6% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.74 | +27.6% |
| FY2024 | -$1.02 | -13.8% |
| FY2023 | -$0.89 | -29.9% |
| FY2022 | -$0.69 | -32.5% |
| FY2021 | -$0.52 | +76.6% |
| FY2020 | -$2.22 | +49.0% |
| FY2019 | -$4.35 | +87.5% |
| FY2018 | -$34.91 | -2569.3% |
| FY2017 | -$1.31 | -160.2% |
| FY2016 | -$0.50 | +62.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026